Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to ...

Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in ...

Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a ...

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the success of AlphaFold, the company aims to speed up drug development in ...

European technology companies are commanding attention on the global stage, with several securing massive funding rounds that ...

For the first of these tasks Dr Baker and his colleagues use RF diffusion, an AI model they have developed to predict a ...

Venture capital investment into the UK has stormed ahead of its European counterparts after AI dominated fresh rounds of ...

Isomorphic Labs has raised a whopping $600 million to refine its artificial intelligence-powered drug discovery engine, advance its pipeline, and expand its headcount in its first external funding ...